AMGEN GmbH
- Pharmaceutical Sales 2009
-
Worldwide: 14.6 billion US $
- Product Range
- Biologics for the treatment of kidney failure, colorectal cancer, ITP, supportive cancer therapie, primary and secondary hyperparathyreoidism, postmenupausal osteoporosis, bone atrophy due to hormon ablation
- Key Research Areas
- Oncology, nephrology, rheumatology, diabetes, endocrinology, neurology, cell therapy
- R&D Expenditure 2009
-
Worldwide: 2.7 billion US $
- Employees in the Pharmaceuticals Division 2009
-
Worldwide: 17,000
In Germany: 350
(All data based on corporate information, as of: 07/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page